SARS-CoV-2 is the causative agent of coronavirus (known as COVID-19), the virus causing
the current pandemic. There are ongoing research studies to develop effective
therapeutics and vaccines against COVID-19 using various methods and many results have
been published. The structure-based drug design of SARS-CoV-2-related proteins is
promising, however, reliable information regarding the structural and intra- and
intermolecular interactions is required. We have conducted studies based on the fragment
molecular orbital (FMO) method for calculating the electronic structures of protein
complexes and analyzing their quantitative molecular interactions. This enables us to
extensively analyze the molecular interactions in residues or functional group units
acting inside the protein complexes. Such precise interaction data are available in the
FMO database (FMODB) (
). Since April 2020, we have performed
several FMO calculations on the structures of SARS-CoV-2-related proteins registered in
the Protein Data Bank. We have published the results of 681 structures, including three
structural proteins and 11 nonstructural proteins, on the COVID-19 special page (as of
June 8, 2021). In this paper, we describe the entire COVID-19 special page of the FMODB
and discuss the calculation results for various proteins. These data not only aid the
interpretation of experimentally determined structures but also the understanding of
protein functions, which is useful for rational drug design for COVID-19.